Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Ultrafast Method Determines Antibiotic Resistance

By LabMedica International staff writers
Posted on 24 Aug 2017
Antibiotic resistance is a growing medical problem that threatens human health globally. More...
One important contributory factor in the development of resistance is the incorrect use of antibiotics for treatment.

Reliable methods to quickly and easily identify bacterial resistance and provide the proper treatment from the start have not been possible because existing antibiotic resistance tests take too long. An antibiotic resistance test has been developed that is fast enough to enable a patient to take the right antibiotic home from the health center straight after the first appointment.

Scientists at Uppsala University (Sweden) developed a point-of-care susceptibility test for urinary tract infection, a disease that 100 million women suffer from annually and that exhibits widespread antibiotic resistance. They captured bacterial cells directly from samples with low bacterial counts (104 colony forming units [cfu]/mL) using a custom-designed microfluidic chip and monitor their individual growth rates using microscopy. By averaging the growth rate response to an antibiotic over many individual cells, they can reduce the detection time to the biological response time of the bacteria.

The microfluidic chip consists of a cover glass and a micro-molded silicon elastomer [polydimethylsiloxane (PDMS)] that are covalently bonded together. For micro-molding, they used the standard soft lithography techniques. Flow direction and rate during the study were maintained by pressure-driven flow. An OB1 Mk III electropneumatic controller regulated the air pressure applied to the closed fluidic reservoirs. The team used an Eclipse Ti-E inverted microscope for automated phase contrast microscopy.

The investigators were able to detect changes in growth rate in response to each of nine antibiotics that are used to treat urinary tract infections in minutes. In a test of 49 clinical uropathogenic Escherichia coli (UPEC) isolates, all were correctly classified as susceptible or resistant to ciprofloxacin in less than 10 minutes. The total time for antibiotic susceptibility testing, from loading of sample to diagnostic readout, was less than 30 minutes, which allows the development of a point-of-care test that can guide correct treatment of urinary tract infection.

Özden Baltekin, a PhD student, who performed most of the laboratory work and is the first author of the study said, “We've developed a new method that allows determination of bacterial resistance patterns in urinary tract infections in 10 to 30 minutes. By comparison, the resistance determination currently in use requires one to two days. The rapid test is based on a new plastic microfluidic chip where the bacteria are trapped and methods for analyzing bacterial growth at single-cell level.” The study was published on August 8, 2017, in the journal Proceedings of the National Academy of Sciences.

Related Links:
Uppsala University


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Collection and Transport System
PurSafe Plus®
Capillary Blood Collection Tube
IMPROMINI M3
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The genomic test measures eight gene activities in a melanoma tumor and combines this data with patient factors like age and tumor thickness (Photo courtesy of 123RF)

Genomic Test Could Reduce Lymph Node Biopsy Surgery in Melanoma Patients

Accurately determining whether melanoma has spread to the lymph nodes is crucial for guiding treatment decisions, yet the standard procedure—sentinel lymph node biopsy—remains invasive, costly, and unnecessary... Read more

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.